Do GLP-1s have a future in Europe?

GLP-1 drugs have not shown as strong an uptake in Europe as in the US. What are the barriers to adoption? Large-scale consumer scepticism in countries such as France, Spain and especially Italy could work against uptake of the drugs, as could wariness of some health services about providing full coverage to consumers.